Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Multicenter Comparison of Computerized Insulin Sensitivity Coefficient and Paper-Based Intravenous Insulin Protocols.
Journal: Journal of diabetes science and technology
Published: July 15, 2026
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease.
Journal: Journal of medicinal chemistry
Published: February 28, 2025
Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer's Disease.
Journal: Journal of medicinal chemistry
Published: June 07, 2024
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19.
Journal: Journal of medicinal chemistry
Published: April 30, 2024
Self-Assembly Properties of an Amphiphilic Phosphate Ester Prodrug Designed for the Treatment of COVID-19.
Journal: Journal of pharmaceutical sciences
Published: April 06, 2023
Evaluation of Procalcitonin's Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 Patients.
Journal: Journal of intensive care medicine
Published: June 17, 2022
Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis.
Journal: Pharmacotherapy
Published: May 07, 2022
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: December 05, 2021
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.
Journal: Science (New York, N.Y.)
Published: November 02, 2021
Harnessing Preclinical Data as a Predictive Tool for Human Brain Tissue Targeting.
Journal: ACS chemical neuroscience
Published: March 02, 2021
Combination of diethyldithiocarbamate with 12-O-tetradecanoyl phorbol-13-acetate inhibits the growth of human myeloid leukemia HL-60 cells in vitro and in xenograft model.
Journal: Bioscience, biotechnology, and biochemistry
Published: July 10, 2020
Last Updated: 11/08/2026